Streptococcus pneumoniae serotype 23F capsular polysaccharide

The **Streptococcus pneumoniae serotype 23F capsular polysaccharide** is a complex carbohydrate structure that forms the outermost layer ("capsule") surrounding *S. pneumoniae* bacteria of the serotype 23F. This capsule is composed of repeating tetrasaccharide units containing D-glucose, D-galactose, L-rhamnose (two residues), glycerol, and phosphate groups arranged in a defined sequence[1][2][8]. The genetic locus responsible for its biosynthesis (*cps23f*) encodes multiple enzymes required for assembly and export of this specific structure[4]. The capsule serves as a **major virulence factor**, enabling *S. pneumoniae* to evade host immune responses—particularly phagocytosis by neutrophils—and is essential for invasive disease potential such as bacteremia and pneumonia[5][7][9]. Because it elicits strong type-specific antibody responses that confer protection against infection with that particular serotype, purified or conjugated forms of this **polysaccharide are used as antigens in pneumococcal vaccines** targeting both children and adults. These vaccines induce active immunity through generation of anti-capsule antibodies which promote bacterial clearance. Serotypes like 23F are included in current multivalent pneumococcal vaccines due to their prevalence among clinical isolates causing invasive disease worldwide. The structural features—such as degree of encapsulation—affect not only virulence but also epidemiological patterns following vaccination campaigns due to phenomena like "serotype replacement"[7]. No evidence suggests misspelling or incorrectness regarding this target; it is well-characterized structurally and functionally within microbiology and vaccinology literature.

Other names

Pneumococcal polysaccharide serotype 23FStreptococcus pneumoniae type 23F capsular polysaccharide antigenStreptococcus pneumoniae Type 23F Polysaccharide Antigen, Apneumococcal capsular polysaccharide type 23F vaccine[6]

Induces active immunity by stimulating production of specific antibodies against the capsule, leading to opsonization and enhanced clearance of the bacteria by immune cells[6][9]